Georgia Institute of Technology
Engineering a Synthetic Hydrogel for Muscle Stem Cell Delivery to the Dystrophic Diaphragm
Abstract
dc:description.abstractDuchenne muscular dystrophy (DMD) is a genetic disorder caused by the absence of dystrophin protein, which serves as structural support between the muscle fiber membrane and extracellular matrix (ECM). Without it, muscles undergo cycles of degeneration and regeneration. Overtime, DMD patients suffer from ambulatory disability and cardiorespiratory failure, the latter of which is a major contributor to premature death. Currently, treatment is primarily palliative and there is no cure. A treatment strategy is to transplant muscle satellite cells (MuSCs) to a target muscle to repopulate the stem cell niche and restore dystrophin to the muscle fibers. Challenges with this strategy include poor cell retention and survival upon transplantation. Delivering MuSCs to the diaphragm muscle, the primary respiratory muscle, poses additional challenges due to its thin morphology and deep-seated location. This project seeks to address these challenges by leveraging hydrogels as a vehicle for localized MuSC delivery to the diaphragm muscle. This objective was accomplished with three aims. In Aim 1, MuSCs were analyzed via flow cytometry to assess integrin expression and hydrogels were synthesized to support their proliferation, differentiation, and migration based on their integrin expression profile. In Aim 2, hydrogel-encapsulated MuSCs were delivered to the diaphragm of dystrophic mice and assessed for engraftment and restored dystrophin. Ultrasound imaging and force testing were used to characterize and monitor changes in the morphology and function of the diaphragm. In Aim 3, dystrophic microtissues were generated in a four-pillar configuration for in vitro dystrophic diaphragm modelling and initial parameters for obtaining and maintaining microtissue yield were established. The results from these Aims will provide support for the therapeutic potential of stem cell delivery for DMD via synthetic hydrogels as well as an in vitro platform to supplement in vivo engraftment studies.
Degree
thesis:*- Name thesis:degree_name
- Biomedical Engineering, PhD
- Department thesis:degree_department
- Biomedical Engineering (Joint GT/Emory Department)
- Grantor
- Georgia Institute of Technology
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Myrie, Nia O.
- Advisor dc:contributor.advisor
-
- García, Andrés J.
- Committee members dc:contributor.committeemember
-
- Jang, Young
- Botchwey, Edward
- Emelianov, Stanislav
- Mourkioti, Foteini
- ORCID person:identifier.orcid
Rights
- Language dc:language.iso
- English
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/1853/81719